Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Brockus

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|May 6, 2009
Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteersMartin Bitzan, Ruth Poole, Mariam Mehran, et al.
The AAPS Journal|July 4, 2015
Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle TechnologyHuijin Dong, Johanna R Mora, Catherine Brockus, et al.
Bioanalysis|June 20, 2020
Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspectiveRenuka Pillutla, Boris Gorovits, Carol Gleason, et al.
Plos One|February 15, 2018
Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infectionScott Balsitis, Volodymyr Gali, Pamela J Mason, et al.
Bioanalysis|January 29, 2026
2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A - Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV))Sarah Hersey, Kristina McGuire, Olga Kholmanskikh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|May 6, 2009
Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteersMartin Bitzan, Ruth Poole, Mariam Mehran, et al.
The AAPS Journal|July 4, 2015
Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle TechnologyHuijin Dong, Johanna R Mora, Catherine Brockus, et al.
Bioanalysis|June 20, 2020
Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspectiveRenuka Pillutla, Boris Gorovits, Carol Gleason, et al.
Plos One|February 15, 2018
Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infectionScott Balsitis, Volodymyr Gali, Pamela J Mason, et al.
Bioanalysis|January 29, 2026
2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A - Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV))Sarah Hersey, Kristina McGuire, Olga Kholmanskikh, et al.
Pageof 1